Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (HKG:9989)
4.820
-0.020 (-0.41%)
Apr 28, 2026, 4:08 PM HKT
9.79% (1Y)
| Market Cap | 16.47B |
| Revenue (ttm) | 6.10B |
| Net Income (ttm) | 388.91M |
| Shares Out | n/a |
| EPS (ttm) | 0.27 |
| PE Ratio | 42.34 |
| Forward PE | n/a |
| Dividend | 0.27 (5.54%) |
| Ex-Dividend Date | May 26, 2025 |
| Volume | 150,500 |
| Average Volume | 377,925 |
| Open | 4.830 |
| Previous Close | 4.840 |
| Day's Range | 4.810 - 4.850 |
| 52-Week Range | 4.320 - 7.260 |
| Beta | 0.45 |
| RSI | 34.69 |
| Earnings Date | Mar 30, 2026 |